Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Ballantyne

Showing results (161-170 of 999) with videos related to

Pageof 100
Sort By:
Atherosclerosis|December 13, 2006
Associations between HDL-cholesterol and polymorphisms in hepatic lipase and lipoprotein lipase genes are modified by dietary fat intake in African American and White adultsJennifer A Nettleton, Lyn M Steffen, Christie M Ballantyne, et al.
Journal of the American College of Cardiology|September 1, 1987
Delayed recovery of severely "stunned" myocardium with the support of a left ventricular assist device after coronary artery bypass graft surgeryC M Ballantyne, M S Verani, H D Short, et al.
Circulation|April 2, 2003
Interaction between soluble thrombomodulin and intercellular adhesion molecule-1 in predicting risk of coronary heart diseaseKenneth K Wu, Nena Aleksic, Christie M Ballantyne, et al.
Stroke|October 8, 2005
Apolipoprotein E genotype and incident ischemic stroke: the Atherosclerosis Risk in Communities StudyJared D Sturgeon, Aaron R Folsom, Molly S Bray, et al.
Annals of Epidemiology|December 12, 2012
Troponin T, B-type natriuretic peptide, C-reactive protein, and cause-specific mortalityOludamilola W Oluleye, Aaron R Folsom, Vijay Nambi, et al.
Atherosclerosis|July 30, 2023
Efficacy and safety of bempedoic acid in patients with and without metabolic syndrome: Pooled analysis of data from four phase 3 clinical trialsMichael D Shapiro, Pam R Taub, Michael J Louie, et al.
Diabetes, Obesity & Metabolism|October 31, 2002
Impact of weight loss on the metabolic syndromeC C Case, P H Jones, K Nelson, et al.
Journal of Clinical Lipidology|August 16, 2021
Greater than expected reduction in low-density lipoprotein-cholesterol (LDL-C) with bempedoic acid in a patient with heterozygous familial hypercholesterolemia (HeFH)Ali M Agha, Peter H Jones, Christie M Ballantyne, et al.
Cardiovascular Drugs and Therapy|April 30, 2004
Fluvastatin reduces cardiac mortality in patients with coronary heart diseaseChristie M Ballantyne, Günter Riegger, Nicholas Moore, et al.
Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals|September 17, 2004
Relationship between low-density lipoprotein subclasses and asymptomatic atherosclerosis in subjects from the Atherosclerosis Risk in Communities (ARIC) StudyD Michael Hallman, Spencer A Brown, Christie M Ballantyne, et al.
Pageof 100

Showing results (161-170 of 999) with videos related to

Sort By:
Pageof 100
Atherosclerosis|December 13, 2006
Associations between HDL-cholesterol and polymorphisms in hepatic lipase and lipoprotein lipase genes are modified by dietary fat intake in African American and White adultsJennifer A Nettleton, Lyn M Steffen, Christie M Ballantyne, et al.
Journal of the American College of Cardiology|September 1, 1987
Delayed recovery of severely "stunned" myocardium with the support of a left ventricular assist device after coronary artery bypass graft surgeryC M Ballantyne, M S Verani, H D Short, et al.
Circulation|April 2, 2003
Interaction between soluble thrombomodulin and intercellular adhesion molecule-1 in predicting risk of coronary heart diseaseKenneth K Wu, Nena Aleksic, Christie M Ballantyne, et al.
Stroke|October 8, 2005
Apolipoprotein E genotype and incident ischemic stroke: the Atherosclerosis Risk in Communities StudyJared D Sturgeon, Aaron R Folsom, Molly S Bray, et al.
Annals of Epidemiology|December 12, 2012
Troponin T, B-type natriuretic peptide, C-reactive protein, and cause-specific mortalityOludamilola W Oluleye, Aaron R Folsom, Vijay Nambi, et al.
Atherosclerosis|July 30, 2023
Efficacy and safety of bempedoic acid in patients with and without metabolic syndrome: Pooled analysis of data from four phase 3 clinical trialsMichael D Shapiro, Pam R Taub, Michael J Louie, et al.
Diabetes, Obesity & Metabolism|October 31, 2002
Impact of weight loss on the metabolic syndromeC C Case, P H Jones, K Nelson, et al.
Journal of Clinical Lipidology|August 16, 2021
Greater than expected reduction in low-density lipoprotein-cholesterol (LDL-C) with bempedoic acid in a patient with heterozygous familial hypercholesterolemia (HeFH)Ali M Agha, Peter H Jones, Christie M Ballantyne, et al.
Cardiovascular Drugs and Therapy|April 30, 2004
Fluvastatin reduces cardiac mortality in patients with coronary heart diseaseChristie M Ballantyne, Günter Riegger, Nicholas Moore, et al.
Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals|September 17, 2004
Relationship between low-density lipoprotein subclasses and asymptomatic atherosclerosis in subjects from the Atherosclerosis Risk in Communities (ARIC) StudyD Michael Hallman, Spencer A Brown, Christie M Ballantyne, et al.
Pageof 100